In order to link these in vitro finding to the events taking place in PDAC in vivo upon treatment, we determined the acid sphingomyelinase activity in orthotopic pancreas carcinoma and in pancreas cancer cells injected into the flank of syngenic C57BL/6 mice. The gene discussed is SMPD1; the disease is pancreatic neoplasm.